James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

A ‘Win’ This Week Would Only be a Minor Victory

The S&P 500 is close to breaking resistance, but there's another big ceiling just above it.

Why Best Buy Co Inc (BBY), AbbVie Inc (ABBV), Smith & Wesson Holding Corp (SWHC) are Three of Today’s Worst Stocks

Smith & Wesson (SWHC), Best Buy (BBY) and AbbVie (ABBV) got the new trading week started on the wrong foot.

Fitbit Inc: The REAL Problem With FIT Stock Is Hard to Fix

Some rabid owners of Fitbit stock are still certain the stock's got a ton of upside in store, but they can't answer one big question.

Why SouFun Holdings Ltd (SFUN), Citigroup Inc (C) and Immunomedics, Inc. (IMMU) Are Three of Today’s Worst Stocks

For Immunomedics (IMMU), SouFun Holdings Ltd (SFUN) and Citigroup (C) shareholders, the week couldn't end soon enough.

Wal-Mart Stores, Inc.: The WMT Comeback Is Just Around the Corner

Walmart (WMT) spent too many years floundering, but recently it went through a much-needed wake-up call, and looks better than it has in a long while.